摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2E,N',E)-3-(4-methoxyphenyl)-N'-[phthalazin-1-(2H)-ylidiene]acrylohydrazide | 1268515-39-4

中文名称
——
中文别名
——
英文名称
(2E,N',E)-3-(4-methoxyphenyl)-N'-[phthalazin-1-(2H)-ylidiene]acrylohydrazide
英文别名
(E)-3-(4-methoxyphenyl)-N-[(Z)-2H-phthalazin-1-ylideneamino]prop-2-enamide;(E)-3-(4-methoxyphenyl)-N'-phthalazin-1-ylprop-2-enehydrazide
(2E,N',E)-3-(4-methoxyphenyl)-N'-[phthalazin-1-(2H)-ylidiene]acrylohydrazide化学式
CAS
1268515-39-4
化学式
C18H16N4O2
mdl
——
分子量
320.351
InChiKey
JZLHNGVCYQSZNP-DHZHZOJOSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    24
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    76.1
  • 氢给体数:
    2
  • 氢受体数:
    5

反应信息

  • 作为产物:
    描述:
    反式-4-甲氧基肉桂酸盐酸肼屈嗪1-羟基苯并三唑盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺三乙胺 作用下, 以 二氯甲烷 为溶剂, 反应 24.0h, 以78%的产率得到(2E,N',E)-3-(4-methoxyphenyl)-N'-[phthalazin-1-(2H)-ylidiene]acrylohydrazide
    参考文献:
    名称:
    Design, Synthesis, and Biological Evaluation of New Cinnamic Derivatives as Antituberculosis Agents
    摘要:
    Tuberculosis, HIV coinfection with TB, emergence of multidrug-resistant TB, and extensively drug-resistant TB are the major causes of death from infectious diseases worldwide. Because no new drug has been introduced in the last several decades, new classes of molecules as anti-TB drugs are urgently needed. Herein, we report the synthesis and structure-activity relationships of a series of thioester, amide, hydrazide, and triazolophthalazine derivatives of 4-alkoxy cinnamic acid. Many compounds exhibited submicromolar minimum inhibitory concentrations against Mycobacterium tuberculosis strain (H(37)Rv). Interestingly, compound 13e, a 4-isopentenyloxycinnamyl triazolophthalazine derivative, was found to be 100-1800 times more active than isoniazid (INH) when tested for its ability to inhibit the growth of INH-resistant M. tuberculosis strains. The results also revealed that 13e does not interfere with mycolic acid biosynthesis, thereby pointing to a different mode of action and representing an attractive lead compound for the development of new anti-TB agents.
    DOI:
    10.1021/jm101510d
点击查看最新优质反应信息

文献信息

  • Design, Synthesis, and Biological Evaluation of New Cinnamic Derivatives as Antituberculosis Agents
    作者:Prithwiraj De、Georges Koumba Yoya、Patricia Constant、Florence Bedos-Belval、Hubert Duran、Nathalie Saffon、Mamadou Daffé、Michel Baltas
    DOI:10.1021/jm101510d
    日期:2011.3.10
    Tuberculosis, HIV coinfection with TB, emergence of multidrug-resistant TB, and extensively drug-resistant TB are the major causes of death from infectious diseases worldwide. Because no new drug has been introduced in the last several decades, new classes of molecules as anti-TB drugs are urgently needed. Herein, we report the synthesis and structure-activity relationships of a series of thioester, amide, hydrazide, and triazolophthalazine derivatives of 4-alkoxy cinnamic acid. Many compounds exhibited submicromolar minimum inhibitory concentrations against Mycobacterium tuberculosis strain (H(37)Rv). Interestingly, compound 13e, a 4-isopentenyloxycinnamyl triazolophthalazine derivative, was found to be 100-1800 times more active than isoniazid (INH) when tested for its ability to inhibit the growth of INH-resistant M. tuberculosis strains. The results also revealed that 13e does not interfere with mycolic acid biosynthesis, thereby pointing to a different mode of action and representing an attractive lead compound for the development of new anti-TB agents.
查看更多